A more sensitive and specific radioenzymatic assay for catecholamines.
This modification of the catechol-O-methyltransferase (COMT) based radioenzymatic assay for norepinephrine (NE) and epinephrine (E) improves sensitivity, selectivity and eliminates many inhibitors of COMT. Prior to assay, samples are extracted into heptane with diphenylborate, then into dilute acetic acid. This extraction procedure has an efficiency of 78% for NE but less than 2% for S-adenosylmethionine (SAM). The extraction procedure also excludes calcium and other COMT inhibitors present in urine, plasma and every tissue tested. This eliminates the requirement for individual standardization of tissue and urine samples. Sensitivity of the assay for NE and E is 10 and 6 pg/ml respectively in 1 ml of plasma. The intraassay coefficients of variation for NE and E are 4 and 13% and the interassay coefficients of variation for NE and E are 10 and 16% in a human plasma sample containing low catecholamine levels. The assay permits quantitation of plasma E levels that were undetectable in prior assays.
Kennedy
B
B
Department of Medicine, University of California, San Diego Medical Center 92103.
Ziegler
M G
MG
D000818:Animals; D001881:Borates / Q000737:chemistry; D002394:Catechol O-Methyltransferase / Q000737:chemistry; D002395:Catecholamines / Q000032:analysis*; D004837:Epinephrine / Q000032:analysis; D006801:Humans; D009638:Norepinephrine / Q000032:analysis; D051381:Rats; D015203:Reproducibility of Results; D012588:Scintillation Counting / Q000379:methods*; D012680:Sensitivity and Specificity
D001881:Borates; D002395:Catecholamines; D002394:Catechol O-Methyltransferase; D009638:Norepinephrine; D004837:Epinephrine